	US 12,458,043 B2
	Bacillus combination for administration to animals
A. Bruce Johnson, Teaneck, NJ (US); and Kenneth W. Bafundo, Teaneck, NJ (US)
Assigned to OmniGen Research, LLC, Corvallis, OR (US)
Filed by OmniGen Research, LLC, Corvallis, OR (US)
Filed on Apr. 12, 2023, as Appl. No. 18/299,499.
Application 18/299,499 is a division of application No. 16/930,577, filed on Jul. 16, 2020, granted, now 11,653,674.
Application 16/930,577 is a continuation of application No. PCT/US2019/014938, filed on Jan. 24, 2019.
Claims priority of provisional application 62/621,196, filed on Jan. 24, 2018.
Prior Publication US 2023/0240326 A1, Aug. 3, 2023
Int. Cl. A23K 10/18 (2016.01); A23K 10/30 (2016.01); A23K 50/75 (2016.01); A23L 33/135 (2016.01)

CPC A23K 10/18 (2016.05) [A23K 10/30 (2016.05); A23K 50/75 (2016.05); A23L 33/135 (2016.08)]

20 Claims

1. A method, comprising administering to an animal a first composition consisting essentially of from 25% to 50% Bacillus subtilis, from 30% to 65% Bacillus licheniformis, from 5% to 30% Bacillus amyloliquefaciens and from greater than zero to 15% Bacillus coagulans, in amounts relative to each other, wherein the first composition does not include any additional direct fed microbial.